
[Federal Register: January 6, 2010 (Volume 75, Number 3)]
[Notices]               
[Page 876]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr06ja10-45]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2009-N-0664]

 
Anesthetic and Life Support Drugs Advisory Committee; 
Cancellation

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The meeting of the Anesthetic and Life Support Drugs Advisory 
Committee scheduled for January 28, 2010, is cancelled. This meeting 
was announced in the Federal Register of December 8, 2009 (74 FR 
64702). This meeting has been cancelled to allow time for the FDA to 
review new information that is relevant to the benefit risk balance for 
the proposed new indication. The agency intends to continue evaluating 
the application and, as needed, will announce future meeting dates in 
the Federal Register.

FOR FURTHER INFORMATION CONTACT: Kalyani Bhatt, Center for Drug 
Evaluation and Research (HFD-21), Food and Drug Administration, 5600 
Fishers Lane (for express delivery, 5630 Fishers Lane, rm. 1093), 
Rockville, MD 20857, 301-827-7001, FAX: 301-827-6776, email: 
Kalyani.Bhatt@fda.hhs.gov, or FDA Advisory Committee Information Line, 
1-800-741-8138 (301-443-0572 in the Washington, DC area), code 
3014512529. Please call the Information Line for up-to-date information 
on this meeting.

    Dated: December 30, 2009.
David Horowitz,
Assistant Commissioner for Policy.
[FR Doc. E9-31306 Filed 1-5-10; 8:45 am]

BILLING CODE 4160-01-S
